Accessibility Menu
 
TerrAscend logo

TerrAscend

(TSX) TSND

Current Price$0.87
Market Cap$268.42M
Since IPO (2017)-28%
5 Year-93%
1 Year+105%
1 Month-4%

TerrAscend Financials at a Glance

Market Cap

$268.42M

Revenue (TTM)

$268.27M

Net Income (TTM)

$86.19M

EPS (TTM)

$-0.40

P/E Ratio

-2.18

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$0.87

Volume

67,657

Open

$0.90

Previous Close

$0.87

Daily Range

$0.86 - $0.90

52-Week Range

$0.30 - $2.00

TSND News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

Industry

Pharmaceuticals

Employees

1,038

CEO

Ziad Ghanem, PharmD

Headquarters

Mississauga, ON L5B 1M5, CA

TSND Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

15%

Net Income Margin

-32%

Return on Equity

-25%

Return on Capital

8%

Return on Assets

-15%

Earnings Yield

-45.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$268.42M

Shares Outstanding

308.53M

Volume

67.66K

Short Interest

0.00%

Avg. Volume

199.08K

Financials (TTM)

Gross Profit

$133.19M

Operating Income

$45.41M

EBITDA

$45.41M

Operating Cash Flow

$22.07M

Capital Expenditure

$8.76M

Free Cash Flow

$13.31M

Cash & ST Invst.

$37.82M

Total Debt

$256.49M

TerrAscend Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$67.16M

-9.7%

Gross Profit

$33.60M

-10.0%

Gross Margin

50.02%

N/A

Market Cap

$268.42M

N/A

Market Cap/Employee

$282.55K

N/A

Employees

950

N/A

Net Income

$2.52M

+107.9%

EBITDA

$10.43M

+134.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$218.67M

-0.3%

Accounts Receivable

$16.87M

-37.9%

Inventory

$33.99M

-30.3%

Long Term Debt

$239.25M

+1.8%

Short Term Debt

$17.19M

+54.3%

Return on Assets

-15.21%

N/A

Return on Invested Capital

8.46%

N/A

Free Cash Flow

$6.40M

+62.7%

Operating Cash Flow

$8.14M

-16.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WEED.TOCanopy Growth Corporation
$1.47-2.00%
ACB.TOAurora Cannabis Inc.
$4.76-1.04%
OGI.TOOrganiGram Holdings Inc.
$1.94-3.73%
DR.TOMedical Facilities Corporation
$16.96+0.89%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About TSND

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.